| scholarly article | Q13442814 |
| P2093 | author name string | Stehouwer CD | |
| Slaats EH | |||
| Smulders YM | |||
| Silberbusch J | |||
| Rakic M | |||
| Weijers RN | |||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 999-1005 | |
| P577 | publication date | 1997-06-01 | |
| P1433 | published in | Diabetes Care | Q5270111 |
| P1476 | title | Determinants of progression of microalbuminuria in patients with NIDDM.A prospective study. | |
| P478 | volume | 20 |
| Q35616168 | A structured review of the relationship between microalbuminuria and cardiovascular events in patients with diabetes mellitus and hypertension |
| Q35087490 | Association of albuminuria and the metabolic syndrome |
| Q31935212 | Better glycaemic control and risk reduction of diabetic complications in Type 2 diabetes: comparison with the DCCT. |
| Q59220162 | Diabetic nephropathy |
| Q38188802 | Dyslipidemia and progression of kidney disease: role of lipid-lowering drugs |
| Q35970697 | Gender difference in albuminuria and ischemic heart disease in type 2 diabetes |
| Q77351860 | Increased plasma apolipoprotein B-containing lipoproteins associated with increased urinary albumin within the microalbuminuria range in type 2 diabetes |
| Q36334542 | Low HDL cholesterol and the risk of diabetic nephropathy and retinopathy: results of the ADVANCE study |
| Q57313704 | Microalbuminuria in patients with Type 2 diabetes mellitus from general practice: course and predictive value |
| Q33617447 | Prevalence of microalbuminuria and its risk factors in type 2 diabetic patients |
| Q78696026 | Protein restriction, glomerular filtration rate and albuminuria in patients with type 2 diabetes mellitus: a randomized trial |
| Q37892300 | Recent advances in the treatment of atherogenic dyslipidemia in type 2 diabetes mellitus |
| Q73428450 | Retinopathy and microalbuminuria in type 2 diabetes: determinants and time-dependency of the association |
| Q35015874 | SOD2 gene Val16Ala polymorphism is associated with macroalbuminuria in Mexican type 2 diabetes patients: a comparative study and meta-analysis |
| Q37311116 | The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in dyslipidaemic patient |
| Q34943447 | The correlates of urinary albumin to creatinine ratio (ACR) in a high risk Australian aboriginal community |
| Q33842530 | The diabetic patient as paradigm for selective antihypertensive therapy |
| Q43801232 | The impact of metabolic and blood pressure control on incidence and progression of nephropathy. A 10-year study of 385 type 2 diabetic patients |
| Q84968686 | Urinary interleukin-6 excretion reflects mean 24-hour systolic blood pressure in type 2 diabetes |
Search more.